Antibiotic Use, Bacterial Co-Infection, and Antimicrobial Resistance in Adults Hospitalized with COVID-19, Influenza, or RSV: A Systematic Review and Meta-Analysis
Antibiotics · 30.06.2026 · 15 (7) · 654
DOI: 10.3390/antibiotics15070654 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 30.06.2026. Verfasst von Florina Cristiana Lucaciu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara, Victor Babeș University of Medicine and Pharmacy, Timisoara.
Abstract (Originalsprache)
Background
Adults hospitalized with COVID-19, influenza A/B, or respiratory syncytial virus (RSV) frequently receive empirical antibiotics, but antibiotic prescribing, confirmed bacterial co-infection, antimicrobial resistance (AMR), and outcomes have not been jointly synthesized across these infections.
Methods
We conducted a PRISMA 2020 systematic review and meta-analysis of 39 studies including 839,531 hospitalized adults. Random-effects models with Freeman–Tukey double-arcsine transformation pooled prevalence estimates; sensitivity and publication-bias analyses were performed where appropriate.
Results
Pooled antibiotic use was 62.56% (95% CI, 53.75–70.97%) for COVID-19, 57.48% (25.76–86.09%) for influenza A/B, and 76.03% (67.62–83.53%) for RSV, with very high heterogeneity. Confirmed bacterial co-infection was lower: 5.31% (3.43–7.56%), 18.66% (9.98–29.30%), and 24.36% (18.53–30.70%), respectively. Prescribing-to-confirmed infection ratios ranged from 3.0 to 46.2. AMR evidence was restricted to COVID-19 studies and was dominated by carbapenem-resistant Gram-negative organisms, mainly in secondary, ICU-associated, or healthcare-associated infections. Confirmed bacterial complications were associated with ICU admission, longer hospitalization, and higher mortality.
Conclusions
Antibiotic prescribing exceeded confirmed bacterial infection across all viral groups, but estimates require cautious interpretation due to heterogeneity, diagnostic uncertainty, observational evidence, and the absence of low-risk-of-bias studies. The evidence base was dominated by COVID-19 cohorts, while influenza A/B and RSV data, especially virus-specific AMR evidence, remain limited. COVID-19-specific AMR findings should not be generalized to influenza A/B or RSV. Virus-specific stewardship should prioritize rapid diagnostics, systematic sampling, reassessment, and de-escalation when bacterial infection is not confirmed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
- Clinical Hospital of Infectious Diseases and Pulmonology "Victor Babes", Gheorghe Adam Street 13, 300310 Timisoara, Romania.
- Department XIII, Discipline of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Department of Diabetes, "Pius Brinzeu" Emergency Hospital, 300723 Timisoara, Romania.
- Second Department of Internal Medicine, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Center of Research and Innovation in Personalized Medicine of Respiratory Diseases (CRIPMRD), "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
ORCID-Profile: Florina Cristiana Lucaciu, Ovidiu Rosca, Ana Maria Mihai, Alexandra Sima, Madalina-Ianca Suba, Norbert Wellmann, Alessia Rosian, Alexandra Bosoanca, Monica Marc
Förderung
- Victor Babeș University of Medicine and Pharmacy Timișoara
- Victor Babeș University of Medicine and Pharmacy, Timisoara
Zitieren
APA
Lucaciu, F. C., Rosca, O., Mihai, A. M., Sima, A., Suba, M. I., Wellmann, N., Rosian, A., Oancea, C., Cialma, M., Tarau, A., Bosoanca, A., & Marc, M. (2026). Antibiotic Use, Bacterial Co-Infection, and Antimicrobial Resistance in Adults Hospitalized with COVID-19, Influenza, or RSV: A Systematic Review and Meta-Analysis. Antibiotics, 15(7), 654. https://doi.org/10.3390/antibiotics15070654
Vancouver
Lucaciu FC, Rosca O, Mihai AM, Sima A, Suba MI, Wellmann N, et al. Antibiotic Use, Bacterial Co-Infection, and Antimicrobial Resistance in Adults Hospitalized with COVID-19, Influenza, or RSV: A Systematic Review and Meta-Analysis. Antibiotics. 2026;15(7):654. doi:10.3390/antibiotics15070654
BibTeX
@article{Lucaciu2026,
author = {Lucaciu, Florina Cristiana and Rosca, Ovidiu and Mihai, Ana Maria and Sima, Alexandra and Suba, Madalina-Ianca and Wellmann, Norbert and Rosian, Alessia and Oancea, Cristian and Cialma, Monica and Tarau, Andrada and Bosoanca, Alexandra and Marc, Monica},
title = {Antibiotic Use, Bacterial Co-Infection, and Antimicrobial Resistance in Adults Hospitalized with COVID-19, Influenza, or RSV: A Systematic Review and Meta-Analysis},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {7},
pages = {654},
doi = {10.3390/antibiotics15070654}
}
EUVIMED